ArticleFrontiers in cellular and infection microbiology2025
HBV genotype distribution and S gene mutations in HIV-HBV co-infected patients: insights from North India.
Article in Frontiers in cellular and infection microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- High Burden of Occult Hepatitis B Infection in HIV-Infected Patients in Southern Vietnam: Insights from Serological and Molecular Analysis.International journal of molecular sciences · 2026Article
- Phage endolysin therapy: a modern antimicrobial strategy against highly drug-resistant superbugs.Archives of microbiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Effective HBV therapy and immunisation require knowledge of HBV mutation rate and genetic variability. This study aimed to characterize HBV genotypes, serotypes, and surface (S) gene mutations among HBV-HIV co-infected and HBV mono-infected patients in North India. Methods: A total of 100 HBV-HIV co-infected and 50 HBV mono-infected patients were enrolled. HBV DNA was extracted from serum using the QIAamp DNA Blood Mini Kit (QIAGEN). HBV viral load was quantified by real-time PCR. The HBV surface gene was amplified using conventional and nested PCR, followed by Sanger sequencing for genotyping, serotyping, and mutational analysis. Genotypes were additionally confirmed using type-specific multiplex PCR. Results: The mean age of HIV-HBV co-infected and HBV mono-infected patients was 36.6 and 34.9 years, respectively. HBeAg positivity was observed in 17% of co-infected and 10% of HBV mono-infected cases. HBV surface gene was successfully amplified in 19 (19%) HIV-HBV co-infected and 20 (40%) HBV mono-infected samples. Genotype D predominated (35/39, 89.7%), with subgenotypes D1 and D3 detected at comparable frequencies, while genotype A was identified in 4 (10.3%) samples, all belonging to subgenotype A1. Serotype analysis showed exclusive association of genotype D with ayw2 and genotype A with adw2. Mutations within the HBsAg 'a' determinant region were identified in 36.8% of HBV-HIV co-infected patients, including nonsynonymous substitutions, whereas no such mutations were observed in HBV mono-infected individuals. Genotype D sequences clustered with subgenotypes D2, D3, and D9 (from West Bengal), as well as D3 (from Russia, Madhya Pradesh, Delhi and Brazil). Conclusion: This study confirms the predominance of HBV genotype D with serotype ayw2 in North India and demonstrates a higher frequency of HBsAg immune escape-associated mutations in HBV-HIV co-infected patients. These findings underscore the importance of ongoing molecular surveillance to inform diagnostic strategies, vaccination effectiveness, and clinical management of HBV, particularly in HIV-affected populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.